🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to evaluate the change in the expression of tr...
Status
Active Not Recruiting
Location
Nebraska Cancer Specialists
Start Date
2024-07-29
Trial ID
NCT06379217
In advanced metastatic castration resistant prostate cancer (mCRPC) progres...
Status
Recruiting
Location
UCLA / Jonsson Comprehensive Cancer Center
Start Date
2024-08-01
Trial ID
NCT06216249
This phase I trial compares the effect of lutetium Lu 177 (177\^Lu)-prostat...
Status
Recruiting
Location
City of Hope Medical Center
Start Date
2026-03-06
Trial ID
NCT07219147
This phase II trial studies how to improve the usage of Lu 177 vipivotide t...
Status
Suspended
Location
Mayo Clinic in Rochester
Start Date
2024-05-03
Trial ID
NCT06200103
Post marketing study on Pluvicto in Korea...
Status
Recruiting
Location
Novartis Investigative Site
Start Date
2025-04-18
Trial ID
NCT06514521
Treatments Being Tested
This phase I trial studies the safety, side effects, and treatment cycle 1 ...
Status
Not Yet Recruiting
Location
University of Michigan Rogel Cancer Center
Start Date
2026-08-01
Trial ID
NCT07682649
In this Phase 2 study, mCRPC patients with PSMA positive scans who progress...
Status
Active Not Recruiting
Location
UC Davis Comprehensive Cancer Center
Start Date
2023-12-11
Trial ID
NCT05682443
Treatments Being Tested
The purpose of this study is to evaluate the efficacy and safety of AAA617 ...
Status
Active Not Recruiting
Location
Rocky Mountain Cancer Centers
Start Date
2024-01-03
Trial ID
NCT05849298
Treatments Being Tested
This is a local prospective, multicenter, long-term, non-interventional stu...
Status
Recruiting
Location
Novartis Investigative Site
Start Date
2025-07-30
Trial ID
NCT07093801
Single-center, non-commercial phase 2 clinical trial to evaluate 177Lu-PSMA...
Status
Recruiting
Location
Maria Skłodowska-Curie National Research Institute of Oncology, Gliwice Branch
Start Date
2025-01-09
Trial ID
NCT06449781
Treatments Being Tested